TAKEDA PHARMACEUTICAL CO LTD has filed 5 insider transactions across 3 companies since April 2023.
Most recent transaction: a transaction of 1250000 shares of Ovid Therapeutics Inc. ($OVID) on December 08, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 8, 2025 | Ovid Therapeutics Inc. | $OVID | TAKEDA PHARMACEUTICAL CO LTD | TenPercentOwner | C | Common Stock | 1250000 | $0.00 | 8,781,996.0000 | 71,212,353 | 16.60% | 1.76% |
| Dec. 8, 2025 | Ovid Therapeutics Inc. | $OVID | TAKEDA PHARMACEUTICAL CO LTD | TenPercentOwner | C | Series A Convertible Preferred Stock | 1250 | $0.00 | 0.0000 | 71,212,353 | 100.00% | 0.00% |
| Sept. 17, 2025 | HilleVax, Inc. | $HLVX | TAKEDA PHARMACEUTICAL CO LTD | TenPercentOwner | U | Common Stock | 6724000 | $1.95 | 0.0000 | 50,141,064 | 100.00% | 13.41% |
| Jan. 24, 2024 | TAKEDA PHARMACEUTICAL CO LTD | $TAK | TAKEDA PHARMACEUTICAL CO LTD | TenPercentOwner | S | Common Stock | 3703703 | $8.10 | 3,755,583.0000 | 1,557,765,596 | 49.65% | 0.24% |
| April 17, 2023 | TAKEDA PHARMACEUTICAL CO LTD | $TAK | TAKEDA PHARMACEUTICAL CO LTD | Other | J | Series A Convertible Preferred Stock | 1000000 | $0.00 | 0.0000 | 1,557,765,596 | 100.00% | 0.06% |